Patrick Terheyden
University Hospital Schleswig-Holstein(DE)University of Lübeck(DE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, CAR-T cell therapy research, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses
Most-Cited Works
- → Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma(2017)1,368 cited
- → Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial(2016)1,206 cited
- → Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma(2018)364 cited
- → Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial(2018)328 cited
- → Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis.(2004)283 cited
- → Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial(2020)240 cited